Tectonic Therapeutic (TECX) Research & Development (2017 - 2026)
Tectonic Therapeutic (TECX) reported Research & Development of $20.9 million for Q1 2026, up 60.1% year-over-year from $13.0 million in Q1 2025, and up 27.72% quarter-over-quarter from $16.3 million in Q4 2025.
Tectonic Therapeutic (TECX) Research & Development (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Research & Development data on file, last reported at $20.9 million in Q1 2026.
- Research & Development for Q1 2026 came in at $20.9 million, up 60.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.3 million (up 63.65% YoY), and the FY2025 annual result was $63.5 million, up 53.49% from the prior year.
- Research & Development advanced to $20.9 million in Q1 2026 per TECX's latest filing, from $16.3 million in the prior quarter.
- Over five years, Research & Development peaked at $20.9 million in Q1 2026 and troughed at $7.1 million in Q2 2024.
- A 5-year average of $14.1 million and a median of $15.9 million in 2022 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2025: Research & Development tumbled 60.35% in 2023, then jumped 142.93% in 2025.
- A 5-year view of Research & Development shows it stood at $18.1 million in 2022, then plunged by 60.35% to $7.2 million in 2023, then rose by 27.31% to $9.2 million in 2024, then jumped by 78.47% to $16.3 million in 2025, then gained by 27.72% to $20.9 million in 2026.
- Business Quant data shows TECX's Research & Development at $20.9 million in Q1 2026, $16.3 million in Q4 2025, and $16.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -58.00 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 20.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.87 Mn |
| Dec 31, 2025 | 16.34 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 17.19 Mn |
| Mar 31, 2025 | 13.04 Mn |
| Dec 31, 2024 | 9.16 Mn |
| Sep 30, 2024 | 14.32 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 10.82 Mn |
| Dec 31, 2023 | 7.19 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 8.77 Mn |
| Mar 31, 2023 | 17.33 Mn |
| Dec 31, 2022 | 18.14 Mn |
| Sep 30, 2022 | 15.92 Mn |
| Jun 30, 2022 | 18.88 Mn |
| Mar 31, 2022 | 19.25 Mn |
| Dec 31, 2021 | 19.00 Mn |
| Sep 30, 2021 | 23.04 Mn |
| Jun 30, 2021 | 22.54 Mn |